Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Asaf Maoz, M.D.

Title
Institution
Department
Address

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Maoz A, Yurgelun MB. Leveraging Electronic Health Record Data to Understand Gaps Underlying the Underdiagnosis of Lynch Syndrome. JCO Clin Cancer Inform. 2024 Jun; 8:e2400032. PMID: 38838279.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  2. Maoz A, Rodriguez NJ, Yurgelun MB, Syngal S. Gastrointestinal Cancer Precursor Conditions and Their Detection. Hematol Oncol Clin North Am. 2024 08; 38(4):783-811. PMID: 38760197; PMCID: PMC11537157.
    Citations:
    Fields: HemHematologyNeoNeoplasmsTranslation:Humans
  3. Vaccaro K, Allen J, Whitfield TW, Maoz A, Reeves S, Velarde J, Yang D, Meglan A, Ribeiro J, Blandin J, Phan N, Bell GW, Hata AN, Weiskopf K. Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. J Clin Invest. 2024 Mar 14; 134(9). PMID: 38483480; PMCID: PMC11060739.
    Citations: 6
    Fields: MedMedicine (General)Translation:HumansAnimalsCells
  4. Naqash AR, Floudas CS, Aber E, Maoz A, Nassar AH, Adib E, Choucair K, Xiu J, Baca Y, Ricciuti B, Alessi JV, Awad MM, Kim C, Judd J, Raez LE, Lopes G, Nieva JJ, Borghaei H, Takebe N, Ma PC, Halmos B, Kwiatkowski DJ, Liu SV, Mamdani H. Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2024 Feb; 8:e2300371. PMID: 38330261; PMCID: PMC10860998.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  5. Tsai YY, Qu C, Bonner JD, Sanz-Pamplona R, Lindsey SS, Melas M, McDonnell KJ, Idos GE, Walker CP, Tsang KK, Da Silva DM, Moratalla-Navarro F, Maoz A, Rennert HS, Kast WM, Greenson JK, Moreno V, Rennert G, Gruber SB, Schmit SL. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer. Front Immunol. 2023; 14:1268117. PMID: 37942321; PMCID: PMC10627840.
    Citations: 2
    Fields: AllAllergy and ImmunologyTranslation:Humans
  6. Maoz A, Weiskopf K. Phagocytic cooperativity by tumour macrophages. Nat Biomed Eng. 2023 09; 7(9):1057-1059. PMID: 37679572.
    Citations:
    Fields: BioBiomedical EngineeringTranslation:HumansCells
  7. Florou V, Floudas CS, Maoz A, Naqash AR, Norton C, Tan AC, Sokol ES, Frampton G, Soares HP, Puri S, Swami U, Wilky B, Hosein P, Trent J, Lopes GL, Park W, Garrido-Laguna I. Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden. J Immunother Cancer. 2023 08; 11(8). PMID: 37586768; PMCID: PMC10432623.
    Citations: 4
    Fields: NeoNeoplasmsTheTherapeuticsTranslation:Humans
  8. Vaccaro K, Allen J, Whitfield TW, Maoz A, Reeves S, Velarde J, Yang D, Phan N, Bell GW, Hata AN, Weiskopf K. Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. bioRxiv. 2023 Mar 06. PMID: 36945559; PMCID: PMC10028834.
    Citations:
  9. Maoz A, Merenstein C, Koga Y, Potter A, Gower AC, Liu G, Zhang S, Liu H, Stevenson C, Spira A, Reid ME, Campbell JD, Mazzilli SA, Lenburg ME, Beane J. Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions. J Immunother Cancer. 2021 09; 9(9). PMID: 34580161; PMCID: PMC8477334.
    Citations: 3
    Fields: NeoNeoplasmsTheTherapeuticsTranslation:HumansCells
  10. Hildebrand LA, Pierce CJ, Dennis M, Paracha M, Maoz A. Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer. Cancers (Basel). 2021 Jan 21; 13(3). PMID: 33494280; PMCID: PMC7864494.
    Citations: 28
  11. Matsuo K, Matsuzaki S, Nusbaum DJ, Maoz A, Oda K, Klar M, Roman LD, Sood AK. Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2021 01; 160(1):32-39. PMID: 33196436.
    Citations: 14
    Fields: GynGynecologyNeoNeoplasmsTranslation:Humans
  12. Ciccone MA, Adams CL, Bowen C, Thakur T, Ricker C, Culver JO, Maoz A, Melas M, Idos GE, Jeyasekharan AD, Matsuo K, Roman LD, Gruber SB, McDonnell KJ. Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells. Gynecol Oncol. 2020 12; 159(3):869-876. PMID: 33032822; PMCID: PMC9893519.
    Citations: 4
    Fields: GynGynecologyNeoNeoplasmsTranslation:HumansAnimalsCells
  13. Sanz-Pamplona R, Melas M, Maoz A, Schmit SL, Rennert H, Lejbkowicz F, Greenson JK, Sanjuan X, Lopez-Zambrano M, Alonso MH, Qu C, McDonnell KJ, Idos GE, Vignali M, Emerson R, Fields P, Guinó E, Santos C, Salazar R, Robins HS, Rennert G, Gruber SB, Moreno V. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis. PLoS Med. 2020 09; 17(9):e1003292. PMID: 32970670; PMCID: PMC7514069.
    Citations: 22
    Fields: MedMedicine (General)Translation:HumansCells
  14. Canakis A, Maoz A, Tkacz JN, Huang C. Factors affecting the rates of adherence to surveillance recommendations for incidental pancreatic cystic lesions in a large urban safety net hospital. BMJ Open Gastroenterol. 2020 07; 7(1). PMID: 32665396; PMCID: PMC7359056.
    Citations: 3
    Fields: GasGastroenterologyTranslation:Humans
  15. Maoz A, Matsuo K, Ciccone MA, Matsuzaki S, Klar M, Roman LD, Sood AK, Gershenson DM. Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review. Cancers (Basel). 2020 May 29; 12(6). PMID: 32485873.
    Citations: 12
  16. Dennis M, Maoz A, Cirstea D, Patel A, Lerner A, Sarosiek S. Treatment disparities in minority groups with multiple myeloma at a safety-net hospital. Leuk Lymphoma. 2020 10; 61(10):2507-2510. PMID: 32460648.
    Citations: 3
    Fields: HemHematologyNeoNeoplasmsTranslation:Humans
  17. Maoz A, Ciccone MA, Matsuzaki S, Coleman RL, Matsuo K. Emerging serine-threonine kinase inhibitors for treating ovarian cancer. Expert Opin Emerg Drugs. 2019 12; 24(4):239-253. PMID: 31755325; PMCID: PMC7526049.
    Citations: 3
    Fields: DruDrug TherapyTranslation:Humans
  18. Batalini F, Aleixo GF, Maoz A, Sarosiek S. Haemodialysis-associated thrombocytopenia: interactions among the immune system, membranes and sterilisation methods. BMJ Case Rep. 2019 Sep 04; 12(9). PMID: 31488440; PMCID: PMC6731774.
    Citations: 1
    Fields: MedMedicine (General)Translation:HumansPHPublic Health
  19. Maoz A, Dennis M, Greenson JK. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer. Front Immunol. 2019; 10:1884. PMID: 31507584; PMCID: PMC6714555.
    Citations: 35
    Fields: AllAllergy and ImmunologyTranslation:HumansAnimals
  20. Weitzel JN, Neuhausen SL, Adamson A, Tao S, Ricker C, Maoz A, Rosenblatt M, Nehoray B, Sand S, Steele L, Unzeitig G, Feldman N, Blanco AM, Hu D, Huntsman S, Castillo D, Haiman C, Slavin T, Ziv E. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer. 2019 08 15; 125(16):2829-2836. PMID: 31206626; PMCID: PMC7376605.
    Citations: 24
    Fields: NeoNeoplasmsTranslation:Humans
  21. Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 03; 94(3):E80-E82. PMID: 30575098.
    Citations: 5
    Fields: HemHematologyTranslation:Humans
  22. Maoz A, Rennert G, Gruber SB. T-Cell Transfer Therapy Targeting Mutant KRAS. N Engl J Med. 2017 02 16; 376(7):e11. PMID: 28207209; PMCID: PMC6172345.
    Citations: 7
    Fields: MedMedicine (General)Translation:HumansCells
  23. Ciccone MA, Maoz A, Casabar JK, Machida H, Mabuchi S, Matsuo K. Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature. Expert Opin Investig Drugs. 2016 Jul; 25(7):781-96. PMID: 27101098; PMCID: PMC7534810.
    Citations: 8
    Fields: DruDrug TherapyTranslation:Humans
  24. Maoz A, Rosenberg S, Leker RR. Increased High-Sensitivity Troponin-T Levels Are Associated with Mortality After Ischemic Stroke. J Mol Neurosci. 2015 Oct; 57(2):160-5. PMID: 26063494.
    Citations: 5
    Fields: MolMolecular BiologyNeuNeurologyTranslation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contact@catalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resources@hms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappt@hms.harvard.edu.
Maoz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.